How The Crowd, VCs & Family Offices Can Join Forces to Fund Breakthrough Medical Technologies | LSI Europe '22

This Panel was Moderated by Oscar Jofre, Co-Founder, President & CEO, KoreConX. He was joined by Panelists: Joseph McGinley, Founder & CEO, McGinley Orthopedics, Marc Giroux, CEO, Kurve Therapeutics, Peter Kassel, CEO, HealthySole, Douglas Ruark, President, Regulation D Resources, and Manny Villafana, CEO of Medical 21.
Speakers
Oscar Jofre
Oscar Jofre
Co-Founder, President/CEO, KoreConX
Joseph McGinley
Joseph McGinley
Founder & CEO, McGinley Orthopedics
Marc Giroux
Marc Giroux
CEO, Kurve Therapeutics
Peter Kassel
Peter Kassel
CEO, HealthySole
Douglas Ruark
Douglas Ruark
President, Regulation D Resources
Manny Villafana
Manny Villafana
CEO, Medical 21

Transcription

Oscar Jofre  0:05  

I'm gonna ask my five esteemed colleagues to join me here. Let's start with Douglas Ruark. He is the CEO of reg D resources in the United States, who provides the legal framework in which in order for you do this, which is great to have him here on board from Colorado, right? All right. And Joseph McGinley, CEO and founder of McGinley, orthopedics innovations. I hope I got that correctly. And Peter Kassel, from HealthySole. If you haven't seen him, he's got a booth here as well. Both of them do. And Mark drew from curve technologies. And I hope you all know Manny. All right, I hope you do. These are the five. Sorry, yes. Well, actually, four I got to learn how to count for leading entrapreneurs that took on this journey, this bumpy journey. I'm not going to sugarcoat it. Because it is bumpy, because everybody wants it to go smooth. But it doesn't. And I've learned that doing this for as long as I have so far. So first, let's start with just some small introductions. I kind of told them your roles. But let's start with you, Doug. Just intro.

 

Douglas Ruark  1:23  

Yeah, absolutely. My name is Doug Ruark. I'm president of Regulation D resources. We're a 23 year old firm that specializes in securities offering preparation work. And then we also build and deploy investor raise portals. And so we cover really the gamut of exempt securities offerings. Obviously, the focus today is on Regulation A plus. And so that's our firm. We're here to get the offering prepared, the filing worked on and then we also can bring the race portal built into play, which would deploy KoreConX technology into the back end. So that's our firm and that's our role in this process. 

 

Joseph McGinley  2:02  

Joe McGinley, and founder and CEO, McGinley Orthopedics. My background is in mechanical engineering and as well as medicine. And what we created, Oscar was talking about stories. Our entire company is built on stories, we actually literally have a napkin sketch. That was the basis of our technology that's being used in operating rooms around the world today. Our company has two commercialized products, the IntelliSense, handheld robotics, as well as the lever action, just the radius plates. We have several in the pipeline that we have over 125 issued and pending patents. And most exciting about being up here on the panel today is we just launched our reggae plus round about 48 hours ago. So it is live, you can scan the Invest button, it's as easy as that. Oscar was not sugarcoating that you can literally just put in your credit card and invest in in any of our companies that are now live with the reggae plus.

 

Peter Kassel  2:55  

I'm Peter Kassel, I am co founder and CEO of HealthySole, we produced the first UVC based device for disinfecting the soles of shoes. We have found all kinds of evidence about the contributions that shoes and shoe soles make to the overall contamination within hospitals and controlled areas. We had started well before COVID even began, we just had the evidence and the personal experiences to know what can happen to people in terms of going into a hospital and potentially acquiring an infection that they didn't arrive with. And we've now been opened with a reggae for three weeks, it was really something that was very special to us first is that I nor nor my co founder had any prior experience within the med tech space. So getting institutional investment was initially very difficult. And as well, our product has a very strong emotional aspect. Once we describe it to people, lots of people go home and they take their shoes off when they go home. And the idea that you'll go from patient to patient to patient in the same shoes and track every infection that were every disease in which you've come into contact with from patient to patient. People understood it so much. So you know prior to learning about the reggae, we tell somebody the story of our company, and they say I wish that was outside of where my mother was being treated. I wish this was in my kid's nursery. I wish I could have this for my home. And so when we learned about the reggae, we understood we had a story that resonated with people and that this was really one of the best ways we could go out and get get capital.

 

Marc Giroux  4:29  

Hello, my name is Marc Giroux. I'm the Chairman and CEO of Kurve Therapeutics. Our company started fairly organically because I started as the first patient. We were I was just trying to find a solution to chronic sinusitis and the terrible allergies I suffered from and I've had five sinus surgeries and it always comes back so I would just say alright, we got to do better job delivering drugs in the nasal cavity. Once we were able to demonstrate we could do Pretty much anywhere in the nasal cavity that we wanted the nose to brain, people came calling because the idea that you could deliver drugs to the brain through the olfactory region was novel, but nobody could actually get there to find out if it was possible. And so we came along, and we did it. And it grew from there. So we demonstrated we could do it with Alzheimer's early on, and then everybody started calling and we ended up in 22, different human use clinical trials, for a whole range of things. Alzheimer's is our lowest hanging fruit. Right now, and in the course of this, this journey we're on right now. But the Regulation A plus was a really attractive option for us. Because we have, we're moving into the phase of our company where everything we're going to do is going to be enormously expensive. And while we work well at institutions, there's more to do. And the great story about reggae plus is, you know, everybody gets to be part of the community. If everybody here knows someone who has some neurodegenerative disease, whether it's Parkinson's, or Alzheimer's, or ALS, or what have you, and you get to have that opportunity to play, right, you get to be joined the community, be part of the club, you know, for a $600 investment, you can say I contributed in a very credible way at getting us over the finish line. And we want everybody to know that they can play that part and play a role in our success. So we want to reach everybody and Oscars numbers have just the US alone, you know, could put us over the top at any point if we could if we could reach the people and tell them to click the invest now button.

 

Manny Villafana  6:45  

Hi, I'm Manny Villafana, serial entrepreneur, I guess, founder, Chief Executive Officer for Medical 21. We're here financing our company through the Reg A. we have developed a artificial coronary artery for bypass surgery. Working with Oscar and Scott, we were looking at a different way of financing our company because typically in the past, I've been able to do seven IPOs. However, in the technology that we have now, it has taken us six years to develop. And as a result, we still have no revenues. But we need money. Through the Reg A, we feel that we can accomplish our goals of reaching a financing goal of somewhere in the neighborhood of 30 to $40 million. It's been a journey for us, we've been working with him, we both been learning. And I feel sincerely that we will be able to accomplish and reach people like before, that do want to participate in the development what we feel is probably one of the most significant medical products ever. Having been involved with some of the major ones before, believe me when I tell you this one is even better.

 

Oscar Jofre  8:18  

Thank you. And, you know, it's I'm not a medical background at all. And I know all their technologies. Interesting enough, Joseph, if you remember at the last event, you only have to show me the drill. I only had one question, how do they do it today? So uh, but before we get into the second part of the real discussion, is you're obviously hearing the the element, it is a great regulation, it is bumpy, I'm not going to sugarcoat it. And I keep saying that to you. Because you need to be in that type of mindset that, you know, everything can be pre planned. But you know, not always goes according to schedule. Don't just walk us through it really quickly, all the requirements, because you see it from the filing. So let's just walk through that. And then we're going to walk into the the real part, the crowd that discussion of, of today's topic, but let's just give them that background first. Yeah, absolutely.

 

Douglas Ruark  9:15  

So, first of all, and you touched upon it, I think we're at a really interesting time right now, in that you've had a number of things that have changed, and it's really created a dynamic where companies can go out and successfully raise money. The first is the rule changes. You know, anything prior now to the jobs act really looks archaic, as far as the capabilities go. I mean, when you when you looked at what a private company had as far as options to go syndicate capital, it was essentially Regulation D. And that program didn't allow any kind of general solicitation of the public. And so what was interesting was is as you saw social media start developing and the Internet developing, and you had these tools that would allow you to reach a tremendous number of people in a short period of time. To not have those programs advancing was frustrating, because, you know, we had people continually saying, Well, I can't put this raise up on my website, or how can I go out to my customer base. And under the old rules, in the old programs, you weren't allowed to do that. So I think transformational is kind of the best word to describe it. I mean, it really is an entirely new dynamic. Now, with the ability to execute what amounts to a public offering of private securities, I mean, the investor acquisition capabilities of reggae plus, is going to mimic a public offering for these companies. And I think then, the technology piece is another angle, the fact that you can go to one of these raise websites, click the invest button, and in three minutes, you're moving on with your day, and you've just bought securities in a private company is is amazing. And obviously, kudos to you and your technology, Oscar and leading the way there with your company. So it really is an amazing time right now in the industry with reggae, plus, you're allowed to raise up to 75 million in a 12 month period, in the filing work is, is very similar to NS one. So I think that's probably as far as the preparation side goes, you really have to be prepared to come in, and you're going to be creating a filing that has a lot of granularity. This is not a Regulation D with a private placement memorandum where you've got some liberties on how much granularity you're providing. So you aren't going to be coming through a process where it's going to be an S one level filing, the exhibits are going to be similar there as well, you will need to come in with in maintain audited financials. And then you're also required, obviously have a transfer agent on board. And so ultimately, with this, the process is really, you know, getting the filing work done, you're obviously getting a raise portal built, you're getting all of your vendors in place, broker dealers transfer agent. And then, you know, once the offering is prepared for submittal, the SEC it gets submitted, it goes through a qualification process, I think it's important to understand that that's not the SEC trying to determine if you're going to have a successful company, it's really the SEC, looking at the filing and making a decision as to whether or not the disclosures are in place, the exhibits are in order. And then from there, you'll essentially have a qualification where you're qualified. And at that point, the offering can go effective in launch. And so it's, it is interesting in that Regulation A has been around for a long time. So I get a lot of people to the like, where did this reggae program come from? Well, it's actually been around for a significant period of time. But it was also an archaic framework. And tier one reggae Plus, there's two tiers under reggae plus tier one and tier two, pretty much everybody's using tier two, because when you get that offering qualified at the federal level, it's a federally covered security, you can sell it in all 50 States and internationally. So I think when people look at weird reggae plus come from well, it had been there, but the rules were archaic. And so in 2015, when the rule changes happened, it really created a dynamic where you're essentially getting a public offering out of this program without having to go through a true public offering preparation process.

 

Oscar Jofre  13:10  

Great overview, start to finish from the compliance side. So but now we're going to talk to the intrapreneurs, because they're live. And as Joe said, right down to the wire right before the event. So you know what this means. This is really important, you can go to all their website. And legally, I can say this to you. This is really the important aspect of this exercise, these individuals are live. And I can specifically tell you, without being offside with any regulator, that you can go to their website, click the InVEST button, and invest. I mean, think about what I'm really saying, I'm not saying I'll send you a deck, I'm saying you can actually do that right now, while you're listening to them. This is the transformation. And imagine the audience being five times or 100 times bigger than that. But right now we're going to talk a little bit about that audience and the inclusion element. So let's start with you, Joe. I mean, this is you're just starting. But you've been working at this for a while. And it's one of the things that I see with reggae. It's not just about targeting that audience, but it's also bringing everybody else on board, giving that awareness. Tell me about that part of the component, your journey that you're going to,

 

Joseph McGinley  14:23  

you know, ask you that's what we're most excited about is getting the message out to individuals and getting them to be part of our team. Not only are we raising funds, we're building team members, we're building ambassadors to our brand. We're getting people out there to learn about our products that are available to for use right now. They'll talk to their hospitals, they'll talk to their orthopedic surgeons. So there's multiple value points for us as a company in the bigger picture the concept of the reggae plus it just makes sense. You hear a lot about wealth disparity and individuals not having access to wealth. Here it is, you know, we you essentially cut out the middleman and the investor now has the right backed access to private securities, that that was unheard of even 10 years ago. You know, Doug, I know what you're talking about as far as reggae plus, but I didn't know about it a year ago, and I've done a reg D rounds. So you know, it is something new to individuals out there. But the exciting part about it is the access and getting innumerable individuals on your team marketing, the security, marketing the company, and marketing the product.

 

Oscar Jofre  15:27  

Perfect. And actually, Peter, you and I, we were discussing this earlier for lunch, a little bit, but I saw put you on the spot of it. Because you're really going down to the numbers, you're kind of a techie like me. Little geeky there we get we are I know, Joe is as well as we all are. It's good to analyze your information. But you've been live now what 16 weeks, right, 

 

Peter Kassel  15:50  

Three weeks. 

 

Oscar Jofre  15:50  

Three weeks, sorry. And so this is what I said it is where you are painting a nice rosy picture. But the start isn't always the way everybody anticipates. And that's not necessarily a bad thing. But let's talk about your journey right now. Because you've been starting. So tell us how it's been going?

 

Peter Kassel  16:07  

Well, it's been it's been exciting and encouraging. And also, of course, bumpy, there is sort of the excitement on a daily basis of waking up and looking at the list of investors, and understanding that a person I've never met a person that I might not ever meet, pulled out their credit card and literally put down $10,000 in trusting our mission and trusting us, which is an unbelievably encouraging items to see on a daily basis. Even you know, I've had phone conversations with folks, our minimum investment is $116. And I've had conversations with people on the phone because I'm, I'm hands on I go through the numbers, I talked to everybody I can I much to the dismay of my family rarely stop. And just having a conversation with somebody who was going to put in $116 was thrilled about the idea was going to then go out and talk to people about it was an amazing, you know, portion of that. There is also the concern of my job as a CEO, or a big portion of my job is making sure that we have money, money, I need money to do my job, we have a great product, we have great customers in this modern landscape, you can't necessarily scale without money. And, you know, one of the things that comes down to as well when we talk about investors is the research shows the companies with money are the companies that win. And having another option to have, you know, institutional investors smart money, so to speak, connect us with everybody. But what I keep thinking about, even though you know, we had projections, and we haven't yet reached them, and we're moving towards that is that I remember that in their own way, the person who put down $500 $1,000 $116 It's its own form of smart money. I mean, a woman told me that she goes to a church in Arizona of 10,000 parishioners, and she was going to be sharing our information and asking, you know, kindly that people within the church share that information. And that's, you know, a certain level of smart money as well, in which I then saw literally, because I get all the information, a spike of investments from Arizona. And it's it's just, we work we work very much, especially during COVID in a bubble, and to have this unbelievably encouraging and sort of, you know, motivating driving factor that people believe in it. People believe in our mission, people believe in us as a team. It's, it's, it's incredibly valuable.

 

Oscar Jofre  18:30  

It's it is it is a great journey. And you're right, when you start talking to them one by one, you start seeing the impact and and we're going to get to the side where family office and VC comes in. I always save the best for last. And just joke Mark, I mean, obviously not the best. No, I you know, there Look, I I'm a fan of entrepreneurship. I love intrapreneurs. And if I would have given up on the first bump in this whole ecosystem that got started 13 years ago, I would have been doing capital markets where I was at. But you know what? Perseverance, you got to keep going? This is a good thing. It really is. And in your company, you've been live now how many weeks for four weeks. So tell us about your journey so far, and the experiences you're having?

 

Marc Giroux  19:22  

Well, if you take a look around this conference, we the Scott has done a tremendous job of setting these things up. He really knows what he's doing. But the thing about the team that is involved in all of this is ,Doug knows what he's doing. You know what you're doing the whole team around all of this RailTel markets, our broker dealer has been terrific. So the whole process is great, right? So we have we feel really supported that we can get this through and succeed, you know, ultimately, but what we have learned over the last four weeks is so much terms on investor acquisition and that marketing and telling of the message so when we're saying Do you hear telling our story, you know, sell the story? Well, you know, career fields, it has a really important story to tell we think is very interesting. So we have to really count on that marketing to have the people click the invest now button. And really the if if the investor acquisition piece of that is successful, all the other pieces are already in place, right? You're there Rialto. There, Doug is there. And we rely on a lot of Scott's market research as well. So, you know, every piece is here. If the investor acquisition piece comes through the way we hope it will, and we'd like the people we're working with, then this is, this is a this is a ball going out of the park, where we're really excited to be a part of it. 

 

Oscar Jofre  20:42  

Yeah, I do agree with you. It's the storytelling, I think, is the I just did an interview yesterday, late last night. And they asked me what is the most challenging thing to an entrapreneur. And I think the biggest challenge is telling the story. I know it sounds simple to say, but I think it's very difficult, especially if you're inside your company, you believe it to be very technical, or this and that. And sometimes you need someone that knows nothing to come and look at it in then give me your perspective, maybe that is the way to tell it. So there are many different ways to tell the story to get an audience because in this audience, you're reaching in a digital world that meets us through the internet. Okay, so that's one type of audience. But using this regulation allows you something that is quite unique. And that is that the old way, you could only reach investors by knocking on the door on the ones you knew or go to events like this. So can you do an event like this every month, think about this for a moment, write that down, write down the cost the hotel, the airfare and all that. So now with online, you don't need to worry about you create it once, and then you just distributed. And you're distributing it to everyone, not only those who could invest in your company, but also those who might be interested in your company, as customers, ambassadors, potential partners, and now, investors. So the Jobs Act was not to remove venture capital, or private equity, or family offices, it was quite the opposite. It was to include everyone. And today's you probably saw the news. Manny news came out yesterday, I think it was yesterday with a successful you know, announcement of raising $20 million into his company recently will tell us a little bit about that. And your journey as well, in the reg eight world.

 

Manny Villafana  22:50  

I want to start with one thing. I'm the I'm a typical entrepreneur. I develop products, however, that are quite unique. And Phil filled with tremendous amount of risk. As I mentioned before, I've done seven IPOs. So raising capital, we've been quite successful in the past. But we came to this hurdle, that maybe an IPO would not be available to us. When I began talking to Scott, he was telling me about the Reg A. And the first thing he said was that you'll be able to reach the accredited investor, as well as the non accredited investor. Now if you're an entrepreneur, thinking about going to a Reg A the first question, you're going to say, Gee, I'm working that product that's very high risk. I don't know if I want a non accredited investor taking that type of risk. We're reaching out to I call the the Joe the bartender. And what I don't want to happen is that show the bartender decides to sell the bar, sell a couple of kids the farm and everything and putting it on one horse, because we are a high risk situation. And Scott informed me of the basics. He said, Look, Manny, take a look at what you've done before. Okay, you started a little company called CPI. And if I suppose if if Guinness Book of Record held a had a listing that said the fastest IPO ever, I may have won that race because I did my first IPO in 114 days after we open up the doors of the company. We did a second IPO when we did St. Jude and that was done within seven months of opening the door. And and Scott reminded me says I'll bet you Manny that when you did your St. Jude IPO You probably did not have a valve in your hand, you probably had a few sketches on the table, and stuff like that an idea of how to make a valve. And I said, You're right. And he said, But yet, when you do an IPO, you are inviting both the accredited and non accredited investor. So let's take a look at you now, Manny. Right now, you have put somewhere in the neighborhood of six years into the development of artificial artery, it's working quite well, you're ready to go into humans. There is far far less risk than what you were doing when you were developing a pacemaker, developing a heart valve. Furthermore, with the reggae, you have another additional safety barrier, particularly for the non accredited investor. And that is that he or she has to be qualified, Joe to bartender cannot go and sell his bar and sell a couple of kids at a farm and everything embedded on you. We limited that is to say the reg a limit limitation is that a new investor can only invest a maximum of 10% of their annual income. That made me feel much, much more comfortable. Because in fact, we were in the previous companies always having some non accredited investors investing without any control, you still maintain a control doing a Reg A. Now, I was probably one of the first guys that went up to Scott and said, you know, this is great. The name of my company is Medical 21, which represents the 21st century. And we're going to do a financing now in the medical community that is truly a 21st century type of financing. We're gonna reach out to the public, both accredited and non accredited to help participate in helping us finance this project, which is a project that will affect all of us. If there's 100 people in this room, I'm going to tell you that at least 50 of you will, at one point or another be told that maybe we have to do bypass surgery on you. Or maybe on your legs, you're going to need some new vessels implanted so that we get better circulation in those good old legs. Okay. And we can do it without harvesting vessels doing it without scarring. I was talking to one individual today who lost his father. And he said the biggest problem was that when they harvested the vessels out of his legs, he lost total usage of his legs, he actually had a leg amputated. And may it may have been able to be not done if if we never touched the legs. So when we're harvesting vessels, we don't harvest vessels, we actually don't touch the legs, we don't touch the arms. We give the surgeon a vessel within 10 seconds by opening up a little package. We have had an experience now we've been working on this. I think we've been effective about four months. And we were told that the financing would take place similar to a hockey stick, it will start out slow and then grow. So Florida, the slow part has been slow. Okay, the living up to that. But I seen such an increase in activity of the telling the story across the the social media, the sales and marketing of our story, that I feel very confident that we'll accomplish our goal. Now because of this exposure, we recently aim with the help of by the way of Scott we we've been able to reach people that wanted particular individual says I want to commit $20 million to us. Hey, I can sleep a little bit better. Okay, just a little bit better. Anyway, let me just say this that working through a Reg A isn't a it's a totally new approach. I who have done like I said seven IPOs before I've always been doing it a certain way. And this has been a challenging new way, a learning curve for me. I am really pleased with what is being done and we will know the answer in probably two or three more months. If this can be done I'm confident that it will be done. Thank you.

 

Oscar Jofre  30:02  

Thank you. And that is, indeed Oh, that's one thing about the regulation that you have to look at is that look, I had, just recently, it just happened again. And this, these are rarities, it does happen. But we did have a client that raised $5 million in less than 24 hours. It does happen every once in a while. It's it's one of those where it is, but sometimes it does take time. And there are different things you need to do. So we're going to talk a little bit. Now about nudging. So nudging is something that we need to understand it's happening every day. And because these companies are live, they can actually tell you how they're going to nudge you while you're going there. And their sight. See, I get the ability to do that. Everything I'm doing right now I need you to understand, five, six years ago was completely illegal. Everything I've said so far, completely illegal, actually, I would be arrested. But because it is fully compliant with the SEC, everything that these individuals are going to tell you is fully compliant, nudging. What is nudging? Well, all of you have gone shopping online, you bought a plane ticket online, you will know what nudging is. So let's start with you, Joe, how are you nudging investors?

 

Joseph McGinley  31:25  

Well, you know, we have access to data. So we can see individuals that are logging onto our website, we can see how they navigate through that website. And you can assess their interests, the data really is key to nudging, really, it's encouraging, it's trying to make that individual comfortable with your product comfortable with your story and comfortable with that investment. Because for someone for the first time, they're clicking on this and right away, they click on the InVEST button, you want a social security number and a credit card, it raises red flags. So that individual might be a little bit timid about putting that information in. So they'll click on that. But we'll see we saw that that occurred. So that we'll have someone reach out either from realtor or one of our other partners for progress with marketing. And they'll contact that individual, they'll say, hey, you know, I saw you filled out the first page of the application, but you didn't really complete it, what what's the what's the problem, and they'll speak to that person and say, This is what's really happening, this is a registered security, all this information is totally secure. It's like you're buying stocks anywhere else. And that person then will become more comfortable with the process. Depending on the amount of the investment or how much you're considering it'll it'll trigger different flags. And then we can help assist that person become comfortable with the with the transaction, and then become a member of our team.

 

Oscar Jofre  32:42  

So Peter, we were talking about it during lunch. So what are you doing to nudge an investor right now?

 

Peter Kassel  32:48  

Well, we have been doing all kinds of outreach as well, I mean, that that's sort of part of it, right is like a lot of online, you know, we have to think about these shares almost as E commerce. And so you know, a lot of times it'll take touching, you know, the consumer multiple times to do so. So one of the things that we've actually been doing is using ringless voicemails. So essentially, I can leave a personal message to these investors in their voicemail inbox without disrupting their day. So they get a phone call from me, and they get an email from me, I'm willing to answer the questions, obviously, as the scales and many says the hockey stick effect kicks in, there's going to be a limit to how much I'm going to be able to do my job and also interface with people. But early on, these are the folks who truly believe in our mission. These are the biggest believers, these are the people who are really out on the edge supporting us. And as people said, they're our future customers, what we're offering people and what I tell them is, there's sort of this concept of vote with your dollar as a consumer. Well, now you can vote with your dollar as an investor, as somebody who will reap the rewards. Every one of us will enter the medical system, how do we want that to look? What care do we want to have? What do we want our doctor to be doing when providing us care? And we are offering people that opportunity. And when I say to them, what do you want your outcomes to be? What do you want the outcomes of your family to be when I actually speak with people, it puts them over the edge. And this is where our story, which is also going to be necessary for the end customer, right for anybody who's going to eventually be adopting for even compliance use of our product. And so we get that opportunity that again, rarely a CEO gets in his position, which is to speak to the people that will be actually touched by our technology. And what it ends up doing is it provides us this opportunity, I think of raising money as a dump truck. We're going to be looking for the boulders, people here the boulders, but what the reggae does is it allows us to fill the negative space of the truck with sand. And everybody there has a common goal of getting to the same place together and the Mormon You have, the more secure your investment is, the better the company does, the greater the chances of success that has been proven out through economics time and time again. And so it just makes total sense for everybody to get in on the boat together.

 

Oscar Jofre  35:15  

Perfect, Mark. I mean, I know you've only been started with Boston just recently. So have you started any nudging yet?

 

Marc Giroux  35:22  

Are we really have the vote, we've had the discussions and there's what are unique things about how my company works is, a lot of times were more in touch with the patient than the actual doctors are. So we have a lot of patients on a compassionate use basis who are Alzheimer's patients and Parkinson's patients. But they asked me a lot of the questions I know there's a lot of them, I cannot answer, we have to take them back to the neurologist. But we get to interface with a lot of these people and mostly a lot of their caregivers. And we want to we're actually talking about how will we go into do the outreach to a lot of these people curve was built on a grassroots sort of effort, and we want to be able to reach out to those people, you know, there's a lot of opportunities here to make intelligent investments in in companies like curve, where you know, hey, for Christmas, I'm giving you 100 shares of Kurth therapeutics are 100 shares of healthy soul. Right? So, or for your birthday, it's a gift that isn't just, you know,

 

Oscar Jofre  36:22  

it's actually it's, thank you for starting it, because the other two missed it. You know, so one of the nice things about Reg A, because I'm gonna let you both touch on your each other's companies. Because Thank you, Marc. That was that was a great, great point there. Reg A allows you to do something extremely wonderful, fully compliant. Again, I can incentivize you to invest more money in my company by giving you something. So I've had companies give away beer, vodka. In fact, my number one client in the world is brew dog out of the UK, he would give people beer, if they invested more. And obviously, you're not gonna give away your products, you could, but you could nudge them with more shares. So why is this important? So you know, when people hear me say, Oscar, you just, you know, you're just giving away stuff you're not, you're doing what every other vendor in the world is doing to the consumer is training people. And I created a video it, I did it for them. And I never published it. But it was really me booking a flight to London. And when I did that, I went to my airline company. I clicked on the button, they gave me three choices. I take the lowest choice. And I clicked on that. And I thought I was done. No, I wasn't. The airline then gave me five more choices to take that same lower seat to keep increasing the rate, but along the way, it kept nudging me. I'll give you more points. I'll give you a free luggage. I'll give you this. I'll give you that. And along the way. That's exactly what I did. Because I saw the value in what it was getting. So what's happening today is investors, people, human beings, whether educated, not accredited, non accredited doesn't matter. We've seen investors with $150,000 Putting it on their credit card. People go That's insane. No, it's not. It's a free ticket for his family for Christmas. Think about it. Points. So everybody's got a different motivation. But this is something all of you can offer. Right. So Joe, you're doing how many tiers five tiers

 

Joseph McGinley  38:30  

five or six tiers plus early share early bonuses,

 

Oscar Jofre  38:33  

early bonus, and we're doing early shares as well, early shares and that comes to an end when

 

Peter Kassel  38:39  

that comes to an end actually on the 24th at 11:59pm, PST, PST, PST, everybody make a note?

 

Oscar Jofre  38:49  

STC, it's a time sensitive component, again, fully compliant. And and Mark, you haven't started yours yet. Do I know. So each company has the ability to do that. And does this mean that it's any less or any you know of a company because they're doing that? No. There are following the mainstream? No different than every store offers you either a free bag, more points or anything like that. Do you think any less of their brand? Absolutely not you expected. Think about us think about each one of you here today. You have this expectation. You want the dollar but you want $1 more. You don't want $1 anymore. Just we're not being trained. And it's happening even to investing. And this is where companies like you're hearing today have that vantage to do so. Look, we've gone over by a lot of time but as Scott said it was okay right? See said it's okay. Look at that. Yes.

 

Manny Villafana  39:56  

You gotta be careful what you tell Scott. Okay. All right. I tell him something good. You're gonna have to say it again 10 times. Anyway, all kidding aside. Thank you, Scott for that question. First of all, if you did put in, let's say $16,500 When I started St. Jude, which was at the time, the minimum investment, it'd be worth around between 90 and 95 million no correction be worth $92 million today. Okay. The other comparison was that we all know Tesla. I bet you everyone in this conference knows, Tesla. If you took a million dollars on the IPO of Tesla, and you put a million dollars on it today be worth between 250 and $300 million. Not a bad number, you take it all day long, right? Well, someone was looking at some documents that we have on St. Jude, and it's been published and everything. So I'm not telling you out of my memory. This is these are actual published numbers. And basically, it said that if you took you know, using those numbers, if you took a million dollars, when we started St. Jude, and you held it for the same amount of time that you've been holding your Tesla, okay, it would be worth between a billion and a half and $2 billion. And this is the part that people don't understand they know about batteries for cars, and knew this and AI and all these kinds of things. But medical technology, particularly in the area of implantology, where we develop products to be implanted in the body has had a very successful rate of return. I don't know how you can tell that story. That yes, I've lived through several of those examples. But how do you tell the story. And and that's what basically Scott is trying to say. If we can get medical technology to be understood, like everyone understands and electric car, and stuff like that. And in the case of Medical 21 we are dealing with will probably be the single biggest implanted device ever. The other day, I went to my guys, I said, Hey, guys, when can we build 1000 grafts per day? And it kind of look at me so so why do you want to know that? The reason I want to know that is is 1000 Grass per day is only 10% of the market. If you think about that, that's $5 million a day in sales. Okay? If you want to multiply that by 300 days, you're already talking, for for 10% of the market., Over a billion and a half dollars. Wow. That's what I'm doing these days. Well, anyway. Thank you, Scott for putting this together. Oscar as always.

 

Oscar Jofre  43:09  

Yeah, it's a pleasure pleasure at the only thing I'll leave you with is a if you guys want to watch a video by Elon in, I know you brought up the examples of a million dollars, but I'm more down to everyone else. Elon say example is how do you put in $1,000 in my company, prior to going public, it would have been worth $250,000. That's the reality. And to answer your other question, which is really interesting. How do we get that to everybody? Well, the interesting thing is money. Didn't want it, to get it to everybody. So we keep thinking people do not understand science. Really. There's a pharmacy store and everybody corner. I mean, there are drugs there that I don't have a clue, but I just know once from my head eight months from my back pain, I don't need to know anything more than that. I think it's time that you realize that the consumer to your products are ready. It's just someone else in the middle is scared to let that go. Money is competing. And today you have choices. Thank you everyone here today. Please visit McGinley innovations, healthy soul and curved technologies, medical 21. And if you want to speak to myself and Doug, were here as well, thank you so much for taking the time this afternoon.

 

LSI Europe ‘24 is filling fast. Secure your spot today to join Medtech and Healthtech leaders.

September 16-20, 2024 The Ritz-Carlton - Sintra, Portugal Register arrow